Clinical and molecular characteristics of non-small cell lung cancer patients harboring PIK3CA mutations.
Sebastian Michels
No relevant relationships to disclose
Sebastian Yves Friedrich Michels
No relevant relationships to disclose
Matthias Scheffler
No relevant relationships to disclose
Masyar Gardizi
No relevant relationships to disclose
Marc Christiaan Allardt Bos
No relevant relationships to disclose
Lucia Nogova
Consultant or Advisory Role - Roche
Honoraria - Lilly; Novartis; Pfizer; Roche
Other Remuneration - Amgen; Bayer
Katharina Koenig
No relevant relationships to disclose
Jana Fassunke
No relevant relationships to disclose
Carina Heydt
No relevant relationships to disclose
Ihle Michaela
No relevant relationships to disclose
Helen Kuenstlinger
No relevant relationships to disclose
Karin Toepelt
No relevant relationships to disclose
Frank Ueckeroth
No relevant relationships to disclose
Kerstin Albus
No relevant relationships to disclose
Monika Heidi Serke
Consultant or Advisory Role - Boehringer Ingelheim; Roche
Honoraria - Boehringer Ingelheim; Roche
Other Remuneration - Boehringer Ingelheim; Roche
Winfried Randerath
Consultant or Advisory Role - Lilly; Roche
Walburga Engel-Riedel
No relevant relationships to disclose
Sabine Merkelbach-Bruse
No relevant relationships to disclose
Lukas Carl Heukamp
Honoraria - Pfizer; Roche
Reinhard Buettner
No relevant relationships to disclose
Juergen Wolf
No relevant relationships to disclose